Hepatol Gastroenterol 2016; 40: 674—81. PMID: 27825633 12） Jung DH, Tak E, Hwang S, Song GW, Ahn CS, Kim KH, et al. Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence. Liver Transpl 2018; 24: 932—45. PMID: 29710388 13） Hwang S, Moon DB, Ahn CS, Kim KH, Ha TY, Song GW, et al. Risk—based long—term screening for hepatocellular carcinoma recurrence after living donor liver transplantation. Transplant Proc 2013; 45: 3076—84. PMID: 24157040278第9章 治療後のサーベイランス・再発予防・再発治療
元のページ ../index.html#14